Emerald Advisers’s NantHealth, Inc NH Stock Holding History

Emerald Advisers’s Portfolio NH Stock Details NH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-32,434	Closed	-$2.06M	–	258
2017 Q2	$2.06M	Sell	32,434 -3,857	-11%	-$214K	0.09%	134
2017 Q1	$2.7M	Sell	36,291 -7,347	-17%	-$818K	0.11%	140
2016 Q4	$6.51M	Buy	43,638 +1,591	+4%	+$282K	0.28%	106
2016 Q3	$8.29M	Buy	42,047 +27,567	+190%	+$5.07M	0.37%	100
2016 Q2	$2.71M	Buy	+14,480	New	+$3.16M	0.13%	182

Other funds holding NH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HCM

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Emerald Advisers's NH Position: Q3 2017 in Review

Emerald Advisers sold out of NantHealth, Inc (NH) in Q3 2017, closing a stake of 32,434 shares — an estimated $2.06M sold.

Emerald Advisers first reported a position in NH in Q2 2016 and held it in 5 quarters. The position peaked at $8.29M in Q3 2016. 47 funds tracked by Wall St. Rank hold NH as of Q3 2017.

Emerald Advisers reported no remaining NantHealth, Inc position as of Q3 2017 after selling out during the quarter.
Emerald Advisers sold 32,434 NantHealth, Inc shares in Q3 2017, an estimated $2.06M.
Emerald Advisers first reported a position in NantHealth, Inc in Q2 2016 and held it in 5 quarters.
Emerald Advisers's NantHealth, Inc position peaked at $8.29M in Q3 2016.
47 funds tracked by Wall St. Rank held NantHealth, Inc as of Q3 2017.

Based on Emerald Advisers's 13F filing for Q3 2017, filed 30 Oct 2017.